5,530,194, is for the seed specific promoter gene, Bce4, and is the latest in a series of patents related to genetically modified plant oils. * Dyad Pharmaceutical Corp., of Columbia, Md., received patent No...The company said the oligonucleotides bind to RNA, not DNA, and may have applications as diagnostics and antisense drugs. * Imclone Systems Inc., of New York, received patent No
5,526,281, protects the underlying technology. * BioChem Pharma Inc., of Laval, Quebec, received patent No...SIP is used in screening libraries of biomolecules. * Protein Design Labs Inc., of Mountain View, Calif., received patent No
5,526,281, protects the underlying technology. * BioChem Pharma Inc., of Laval, Quebec, received patent No...SIP is used in screening libraries of biomolecules. * Protein Design Labs Inc., of Mountain View, Calif., received patent No
Alexion Pharmaceuticals Inc., of New Haven, Conn., received patent No...The compound is designed to inhibit lactate accumulation by stimulating an enzyme that generates adenosine triphosphate. * MedImmune Inc., of Gaithersburg, Md., received patent No
Protogene Laboratories Inc., of Palo Alto, Calif., received patent No...5,474,796, titled, "Method and apparatus for conducting an array of chemical reactions on a support surface." * Regeneron Pharmaceuticals Inc., of Tarrytown, N.Y., received patent No
The patent is co- owned by the Fred Hutchinson Cancer Research Center, in Seattle. * VivoRx Inc., of Santa Monica, Calif., received a patent covering composition and method for encapsulating biologically active materials, such as cells, in natural and synthetic polymers. * Xoma Corp., of Berkeley, Calif., received two patents related to manufacturing capability and basic research for its bactericidal/permeability-increasing protein (BPI
Integrase is an enzyme that enables HIV to integrate with the human genome. * Athena Neurosciences Inc., of South San Francisco, received patent No...The patent is co- owned by the Fred Hutchinson Cancer Research Center, in Seattle. * VivoRx Inc., of Santa Monica, Calif., received a patent covering composition and method for encapsulating biologically active materials, such as cells, in natural and synthetic polymers. * Xoma Corp., of Berkeley, Calif., received two patents related to
5,530,194, is for the seed specific promoter gene, Bce4, and is the latest in a series of patents related to genetically modified plant oils. * Dyad Pharmaceutical Corp., of Columbia, Md., received patent No...The company said the oligonucleotides bind to RNA, not DNA, and may have applications as diagnostics and antisense drugs. * Imclone Systems Inc., of New York, received patent No